| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/46.3.397 |
| P698 | PubMed publication ID | 10980166 |
| P2093 | author name string | Douglas LJ | |
| Baillie GS | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| P304 | page(s) | 397-403 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. | |
| P478 | volume | 46 |
| Q46885843 | (B1) Candida and mycotic infections |
| Q39011327 | 40 years of medical mycology at JAC. |
| Q28481813 | A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance |
| Q34108567 | A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. |
| Q42942464 | A proteomic analysis of secretory proteins of a pre-vacuolar mutant of Candida albicans |
| Q33323643 | A seed and feed model for the formation of Candida albicans biofilms under flow conditions using an improved modified Robbins device. |
| Q35127891 | A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes |
| Q34932922 | Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells |
| Q39954846 | Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole |
| Q39316488 | Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface. |
| Q36034513 | An In Vitro Model for Oral Mixed Biofilms of Candida albicans and Streptococcus gordonii in Synthetic Saliva |
| Q40232088 | An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus |
| Q42708452 | Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: in vitro and in vivo studies in a Caenorhabditis elegans infection model |
| Q37232404 | Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit |
| Q28818603 | Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis |
| Q34142971 | Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection |
| Q80377173 | Antifungal susceptibility of Candida albicans biofilms on titanium discs with different surface roughness |
| Q37906758 | Antifungal susceptibility of Candida albicans in biofilms |
| Q31058690 | Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins |
| Q33466403 | Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer. |
| Q42285275 | Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. |
| Q91865109 | Association between biofilm formation, structure and antibiotic resistance in Staphylococcus epidermidis isolated from neonatal septicemia in southwest Iran |
| Q52579452 | Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. |
| Q48163318 | Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium |
| Q37392907 | Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates |
| Q28716567 | Biofilm formation by Candida albicans isolated from intrauterine devices |
| Q30705127 | Biofilm formation by Candida dubliniensis |
| Q51079295 | Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. |
| Q38672292 | Biofilm formation in Candida glabrata: What have we learnt from functional genomics approaches? |
| Q33468384 | Biofilm matrix regulation by Candida albicans Zap1. |
| Q86183106 | Candida albicans Amphotericin B-Tolerant Persister Formation is Closely Related to Surface Adhesion |
| Q26778729 | Candida albicans Biofilms and Human Disease |
| Q42545813 | Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance |
| Q36412239 | Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing |
| Q39077924 | Candida albicans biofilms produce antifungal-tolerant persister cells |
| Q40176352 | Candida albicans biofilms: comparative analysis of room-temperature and cryofixation for scanning electron microscopy. |
| Q34747087 | Candida albicans forms biofilms on the vaginal mucosa |
| Q36900101 | Candida albicans: A Model Organism for Studying Fungal Pathogens. |
| Q34161590 | Candida biofilms |
| Q35044563 | Candida biofilms and their role in infection |
| Q30475833 | Candida biofilms: an update |
| Q40424798 | Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. |
| Q38019018 | Candida species: new insights into biofilm formation. |
| Q42563149 | Carbohydrate Derived Fulvic Acid: An in vitro Investigation of a Novel Membrane Active Antiseptic Agent Against Candida albicans Biofilms |
| Q38553424 | Changes in Candida albicans colonization and morphology under influence of voriconazole |
| Q34293687 | Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis |
| Q44390209 | Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms |
| Q35280502 | Community participation in biofilm matrix assembly and function |
| Q38385358 | Comparative Ploidy Proteomics of Candida albicans Biofilms Unraveled the Role of the AHP1 Gene in the Biofilm Persistence Against Amphotericin B. |
| Q30799502 | Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces |
| Q35115078 | Confocal analysis of the exopolysaccharide matrix of Candida albicans biofilms. |
| Q52333026 | Conservation and Divergence in the Candida Species Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. |
| Q89578301 | Contributions of the Biofilm Matrix to Candida Pathogenesis |
| Q33250085 | Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. |
| Q46828052 | Denture disinfection by microwave energy: influence of Candida albicans biofilm |
| Q42440128 | Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability. |
| Q37523933 | Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. |
| Q34119405 | Development and validation of an in vivo Candida albicans biofilm denture model. |
| Q92219489 | Effect of Clove and Thyme Essential Oils on Candida Biofilm Formation and the Oil Distribution in Yeast Cells |
| Q34399977 | Effects of salivary protein flow and indigenous microorganisms on initial colonization of Candida albicans in an in vivo model |
| Q62470827 | Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of spp. clinical isolates |
| Q42280529 | Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model |
| Q39450212 | Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. |
| Q34556646 | Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents |
| Q27930431 | Flo11p, drug efflux pumps, and the extracellular matrix cooperate to form biofilm yeast colonies. |
| Q39226110 | Fungal Biofilms: Inside Out. |
| Q37887512 | Fungal Biofilms: Relevance in the Setting of Human Disease |
| Q38817837 | Fungal Biofilms: Update on Resistance |
| Q36148245 | Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions. |
| Q35821475 | Fungal biofilm resistance |
| Q34540389 | Fungal biofilms and drug resistance |
| Q34355341 | Fungal biofilms, drug resistance, and recurrent infection |
| Q38186068 | Future directions for anti-biofilm therapeutics targeting Candida |
| Q33508236 | Genes selectively up-regulated by pheromone in white cells are involved in biofilm formation in Candida albicans |
| Q37824380 | Genetic control of Candida albicans biofilm development |
| Q36539594 | Genetics and genomics of Candida albicans biofilm formation |
| Q33994260 | Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans |
| Q34339377 | Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm |
| Q34684434 | Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31. |
| Q37557700 | Human fungal pathogen Candida albicans in the postgenomic era: an overview. |
| Q41595742 | Human serum potentiates the expression of genes associated with antifungal drug resistance in C. albicans biofilms on central venous catheters |
| Q37263594 | Impact of environmental conditions on the form and function of Candida albicans biofilms |
| Q35490098 | Importance of Candida-bacterial polymicrobial biofilms in disease |
| Q53641731 | In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. |
| Q43094518 | In vitro biofilm activity of non-Candida albicans Candida species. |
| Q34251150 | In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D. |
| Q33455239 | Inactivation of Candida biofilms by non-thermal plasma and its enhancement for fungistatic effect of antifungal drugs |
| Q42681379 | Inactivation of genes TEC1 and EFG1 in Candida albicans influences extracellular matrix composition and biofilm morphology |
| Q35091118 | Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. |
| Q50720707 | Influence of starvation, surface attachment and biofilm growth on the biocide susceptibility of the biodeteriogenic yeast Aureobasidium pullulans. |
| Q35023504 | Inhibition of fungal colonization by Pseudoalteromonas tunicata provides a competitive advantage during surface colonization |
| Q35076919 | Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm |
| Q35974693 | Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. |
| Q40335405 | Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans |
| Q35598281 | Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. |
| Q35110350 | Involvement of glycolysis/gluconeogenesis and signaling regulatory pathways in Saccharomyces cerevisiae biofilms during fermentation |
| Q34237946 | Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights |
| Q40467892 | Large-scale production and isolation of Candida biofilm extracellular matrix. |
| Q64120011 | Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Pathogens |
| Q26827521 | Mechanisms of Candida biofilm drug resistance |
| Q44910278 | Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans |
| Q34198338 | Multi drug resistance in strong biofilm forming clinical isolates of Staphylococcus epidermidis |
| Q37119022 | Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces |
| Q33843060 | Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms |
| Q38441157 | Null mutants of Candida albicans for cell-wall-related genes form fragile biofilms that display an almost identical extracellular matrix proteome |
| Q35805382 | Origins of variation in the fungal cell surface |
| Q37622959 | Our current understanding of fungal biofilms |
| Q36094887 | Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species |
| Q38767464 | Pathogenesis of Candida albicans biofilm |
| Q33326460 | Pathogenesis of mucosal biofilm infections: challenges and progress |
| Q52944713 | Patterns in Saccharomyces cerevisiae yeast colonies via magnetic resonance imaging. |
| Q39955289 | Penetration of Candida biofilms by antifungal agents |
| Q38665270 | Protein O-mannosyltransferase isoforms regulate biofilm formation in Candida albicans |
| Q63352286 | Proteomics Approaches to Uncover the Drug Resistance Mechanisms of Microbial Biofilms |
| Q35635952 | Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. |
| Q34595925 | Rat indwelling urinary catheter model of Candida albicans biofilm infection |
| Q38131290 | Recent insights into Candida albicans biofilm resistance mechanisms |
| Q36870880 | Reduced biocide susceptibility in Candida albicans biofilms |
| Q38373781 | Resistance of Candida albicans Biofilms to Drugs and the Host Immune System |
| Q35878982 | Role for cell density in antifungal drug resistance in Candida albicans biofilms |
| Q41629515 | Role of Tec1 in the development, architecture, and integrity of sexual biofilms of Candida albicans |
| Q39767233 | Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. |
| Q34643153 | Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase |
| Q42233249 | Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. |
| Q44019485 | Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms. |
| Q51555264 | Simple and reliable detection of slime production of Candida spp. directly from blood culture bottles: comparison of visual tube method and transmission electron microscopy. |
| Q35063771 | Spaceflight enhances cell aggregation and random budding in Candida albicans. |
| Q34509773 | Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro |
| Q37713399 | Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. |
| Q28082407 | Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans |
| Q43063852 | Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms |
| Q46790530 | Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm |
| Q33684840 | The Candida albicans Biofilm Matrix: Composition, Structure and Function |
| Q42021068 | The Comparative Evaluation of the Antimicrobial Effect of Propolis with Chlorhexidine against Oral Pathogens: An In Vitro Study |
| Q38153458 | The Eagle-like effect of echinocandins: what's in a name? |
| Q38856993 | The Extracellular Matrix of Fungal Biofilms |
| Q49203638 | The Interface between Fungal Biofilms and Innate Immunity |
| Q90641600 | The Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective |
| Q36993853 | The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. |
| Q40250981 | The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting |
| Q58567516 | The antifungal agent of silver nanoparticles activated by diode laser as light source to reduce C. albicans biofilms: an in vitro study |
| Q29547334 | The biofilm matrix |
| Q38009721 | The effect of biomaterials and antifungals on biofilm formation by Candida species: a review |
| Q31171634 | The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms |
| Q35175164 | Time course global gene expression analysis of an in vivo Candida biofilm. |
| Q38327686 | Transcriptional profiling of Saccharomyces cerevisiae cells under adhesion-inducing conditions |
| Q37728800 | Transcriptional response of Candida albicans biofilms following exposure to 2-amino-nonyl-6-methoxyl-tetralin muriate |
| Q28478073 | UDP-glucose 4, 6-dehydratase activity plays an important role in maintaining cell wall integrity and virulence of Candida albicans |
| Q37975962 | Unraveling the resistance of microbial biofilms: has proteomics been helpful? |
| Q44212359 | Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment |
| Q84867030 | [Could antifungal lock be useful in the management of candidiasis linked with catheters?] |
Search more.